DHX9-mediated pathway contributes to the malignant phenotype of myelodysplastic syndromesNanfang Huang(Shanghai Sixth People's Hospital), Feng Xu(Shanghai Sixth People's Hospital)iScienceMay 26, 202310.1016/j.isci.2023.106962Cited by 9SaveCiteExport RISWatch citationsRelated PapersRigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome|Scientific Reports|2014|49Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome|Oncotarget|2016|34